A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HDAC / high-dose Ara-C

[Related PubMed/MEDLINE]
Total Number of Papers: 11
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HDAC  (>> Co-occurring Abbreviation)
Long Form:   high-dose Ara-C
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection. AI, AML, BLR, GANITE, IDA, KNN, LogR, LR, MCGANs, SVM
2017 Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO). ASCT
2014 Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia. AML, MRD
2012 A randomized comparison of modified intermediate-dose Ara-C versus high-dose ara-c in post-remission therapy for acute myeloid leukemia. AML, CR, WBC
2009 Core binding factor acute myeloid leukemia (CBF-AML): is high-dose Ara-C (HDAC) consolidation as effective as you think? CBF-AML
2005 Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients. allo, AML, auto-SCT, CR, ICE
2003 Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients. DFS, FLAG-Ida, OS
1999 Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity. ---
1997 Treatment of adult patients with relapsed or refractory acute lymphoblastic leukemia (ALL). ALL, CR
10  1994 Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults. ALL, CR
11  1993 Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia. FA, IDAC